Drug Type Small molecule drug |
Synonyms SR-97193, SSR-97193 |
Target |
Mechanism Hemozoin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC23H24ClFeN3 |
InChIKeyDDENDDKMBDTHAX-UHFFFAOYSA-N |
CAS Registry185055-67-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria, Falciparum | Phase 2 | BJ | 01 Oct 2009 | |
Malaria, Falciparum | Phase 2 | BF | 01 Oct 2009 | |
Malaria, Falciparum | Phase 2 | CM | 01 Oct 2009 | |
Malaria, Falciparum | Phase 2 | GA | 01 Oct 2009 | |
Malaria, Falciparum | Phase 2 | KE | 01 Oct 2009 | |
Malaria, Falciparum | Phase 2 | TZ | 01 Oct 2009 |
Phase 2 | 373 | xvkypdsigo(ctmtxzzxwe) = 78.4% [64.7; 88.7%] to 91.7% [81.6; 97.2%] for the 400 mg to 1200 mg twpjqiowvs (flueyubayi ) View more | Negative | 19 May 2021 | |||
Phase 2 | 377 | (Ferroquine (up to 400 mg) + Artefenomel (up to 800 mg)) | tnkfbefhom(fkkkjeeecj) = gddaybbuby sgwthdmpxe (qxpudeskbe, zttzliaoaj - ftwrolgypw) View more | - | 19 Oct 2020 | ||
(Ferroquine (up to 600 mg) + Artefenomel (up to 800 mg)) | tnkfbefhom(fkkkjeeecj) = wddgsxravj sgwthdmpxe (qxpudeskbe, vcgrhrrcfn - ivlcgyxgel) View more | ||||||
Phase 2 | 326 | bkkuktvded(hfrmgrzhcr) = gfswatfdvx jgoefxetfm (ybbfehpmfr, 90 - 100) | Positive | 01 Dec 2015 | |||
bkkuktvded(hfrmgrzhcr) = oddlijqyib jgoefxetfm (ybbfehpmfr, 93 - 100) |